VIEKIRA XR FDA approval date
The FDA approved VIEKIRA XR on 22 Jul 2016.
- FDA approval date
- 22 Jul 2016
- Source
- FDA record
Drug identity has not yet been verified against registry records
Also recorded as DASABUVIR SODIUM; OMBITASVIR; PARITAPREVIR; RITONAVIR
Included trials
No linked trials for this drug yet. Browse all trials
PDUFA dates and FDA decisions
| Date as reported | Drug / company | Event | Condition | Evidence |
|---|---|---|---|---|
| 2016-07-22Day | VIEKIRA XR | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA208624", "applicant_as_listed_by_fda": "ABBVIE", "brand_names": ["VIEKIRA XR"], "active_ingredients": ["DASABUVIR SODIUM", "OMBITASVIR", "PARITAPREVIR", "RITONAVIR"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20160722", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |